New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer

New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a new liquid biopsy test that can be used to predict risk of early disease progression in women with metastatic breast cancer. This could help oncologists by optimizing the use of available and effective therapies with the goal of achieving better clinical outcomes and prolonging survival. Read more about the study here.

SEE ALL NEWS
Recent Posts
Reduce Your Breast Cancer Risk Novel Blood Test May Detect Cancer Stress Busters: 4 Integrative Treatments Mammogram Age Guidelines: What You Need to Know Transcription Factors Contribute to Subtypes of Colorectal Cancers Johns Hopkins Hepatologists Detect Liver Cancer in Urine Test Johns Hopkins Surgeons Pioneer Combination of Procedures for Patients with Advanced Colorectal Cancer How to Make a Healthy Smoothie Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines